Rapid Dose Therapeutics Corp. (DOSE.CN)
Canadian Sec · CAD · Healthcare · Biotechnology
CA$0.10 (+5.26%) as of
Key statistics
- Market cap
- 13.78M
- EPS (TTM)
- -0.0400
- Dividend yield
- 0.00%
- 52-week range
- 0.0800 – 0.1900
- Beta
- -0.85
- Revenue (TTM)
- 2.58M
- Profit margin
- -123.09%
- Volume
- 3.20k
About Rapid Dose Therapeutics Corp.
Rapid Dose Therapeutics Corp., a life sciences company, provides drug delivery technologies in Canada. The company offers QuickStrip/PharmaStrip, an oral fast-dissolving drug delivery system designed to rapidly release pharmaceuticals, emulsified oils, and over-the-counter medicines into the bloodstream. It also provides over-the-counter products consisting of QuickStrip Energy to deliver energizing caffeine; QuickStrip B12 to deliver vitamin B12; and QuickStrip Sleep to deliver melatonin, as well as dental products including Lidocaine QuickStrip, a muco-adhesive oral thin film. It also engages in the research, production, provision, and distribution of technical services for the delivery of oral thin film strips containing active ingredients. In addition, the company is involved in the sale of health and wellness products, such as nutraceuticals; white label manufacturing, including oral thin film strips containing active ingredients under cannabis licensing; and the provision of consulting services for the application of active ingredients with the oral thin film polymer formulation and processes. Rapid Dose Therapeutics Corp. is headquartered in Burlington, Canada.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Burlington, ON, Canada
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.